Wallace DJ, Ginzler EM, Merrill JT, et al. Sustained safety and efficacy over 10 years with belimumab (BEL) plus standard systemic lupus erythematosus (SLE) therapy (SOC) in patients with SLE. EULAR 2017, #OP0232.
Door corona dreigt wereldwijd tekort aan tocilizumab
sep 2021 | Arteriitis, Immuuntherapie, JIA, Lymfoom, RA, Virale infecties